Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Z-DNA binding protein 1 (ZBP1), also known as DAI, is a critical cytosolic innate immune sensor that specifically recognizes the high-energy, left-handed Z-conformation of nucleic acids (Z-DNA and Z-RNA) [1]. It plays a pivotal role in detecting viral pathogens, such as influenza A virus, by sensing viral Z-RNA and triggering inflammatory signaling or programmed cell death pathways [2, 3]. Upon activation, ZBP1 recruits RIPK3 and other signaling molecules to initiate necroptosis, apoptosis, or pyroptosis (collectively termed PANoptosis), thereby eliminating infected cells [4]. Beyond its role in infection, ZBP1 can be activated by endogenous Z-DNA induced by cellular stress or small molecules like curaxins, making it a promising target in oncology for inducing immunogenic cell death in tumors [5]. However, dysregulated ZBP1 signaling is also a major driver of pathology in autoinflammatory diseases and chronic inflammation, where it mediates significant tissue damage [6]. Sources: [1] UniProt (Q9H171); [2] Kuriakose et al., Science Immunology (2016) 1(2):aag2671; [3] Zhang et al., Nature (2020) 580:392–396; [4] Kesavardhana et al., Nature (2020) 580:397–402; [5] Gurova et al., BioEssays (2018) 40(10):1800134; [6] Jiao et al., Nature (2020) 580:386–391.
ZBP1 functions as a cytosolic sensor for left-handed Z-form nucleic acids. Small molecules such as curaxins (e.g., CBL0137) intercalate into the DNA double helix and induce a transition from B-DNA to Z-DNA. ZBP1 recognizes these Z-DNA structures via its N-terminal Zα domains, which triggers a conformational change and the recruitment of RIPK3 through RHIM-RHIM domain interactions. This assembly initiates downstream signaling pathways that lead to the production of type I interferons or the induction of programmed cell death, specifically necroptosis, via MLKL phosphorylation [1, 5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Z-DNA binding protein 1 (ZBP1) (ZBP1).